Atlas
ActiveEvery 24hPatent overlap as threat: Watch new claims that could collide with your work. Prioritize claims, continuations and family members that read on your project.
Scanned 9 min ago
- USPTO
- EPO
- WIPO
- JPO
- KIPO
- CNIPA
Visibility
We find the competitors you didn’t know to look for.
Lapis Lumen is continuous competitive intelligence for biotech and deep-tech R&D. Our autonomous research agents watch external developments (patents, scientific publications, clinical trials, grants, competitor activity) and surface what could affect your program before it becomes obvious.
2 million new records a week. We track every one for you.
We give you 14 months of warning, from the public record.
Lead time you gain
0.0mo
- −14 moUSPTO · Northwind Therapeutics
- −11 moNIH RePORTER · Delta Lab
- −7 mobioRxiv · Delta Lab
- −5 moTechCrunch · Northwind Therapeutics
- −3 moLinkedIn · Northwind Therapeutics
- TodayEveryone else catches up.
Live detections
PATENTUS-PAT-20264117
USPTO · BostonREL 94%
PAPEREP-PAP-20261908
arXiv · MunichREL 81%
PATENTJP-PAT-20268442
JPO · TokyoREL 76%
- 1.6B+Patents, papers and grants indexed
- 61Countries monitored
- 2MNew records indexed weekly
- +0Records ingested since you arrived
Autology
Research partners, programs, and press across Canada and the US
02 / The gap
Make multi-million dollar decisions on all of the available science.
Most teams find out about a development months after it’s public. Two million new records appear every week.
No team can read that. Lapis Lumen reads all of it for you.
Volume vs. attention
Year
Papers / yr
M
Beyond capacity
×
Sources:NSF Science & Engineering Indicators ·Scopus1996 → 2024 recorded · 2025 → 2035 projected
03 / How Lapis Lumen works
From your technology to ongoing intelligence.
Tell Lapis Lumen what you are building, brief its research agents, and review what they bring back.
Explore the productBuild your project1 / 3
Add your project context.
Your documents, research and priorities. That context tells the research agents what matters to you.
04 / Research agents
Autonomous research agents.We built them to do the reading.
Each agent works on a mission of its own: patents, papers and preprints, trials and regulatory filings, grants and funding, companies and news, or the organizations you name.
Atlas, Reads patents
Mission
What this agent watches, in plain language. Retask, pause or narrow it any time.
05 / What it watches
Global science, watched continuously.
Patent offices, regulators, institutions, filings, and collaborations connect across the jurisdictions and organizations moving your field.
- Patent office
- Institution
- Regulator
- Science cluster
Every office the globe is watching: 61 jurisdictions in the indexed corpus.
Select a flag to see what Lapis Lumen covers in that office
Sources monitored
- USPTO
- EPO
- WIPO
- CNIPA
- JPO
- KIPO
- PubMed
- bioRxiv
- arXiv
- Europe PMC
- ClinicalTrials.gov
- FDA
- Google Patents
- NIH RePORTER
- EMA
- OpenAlex
- Semantic Scholar
- CORE
- CIPO
- IP Australia
- DPMA
- INPI France
- INPI Brazil
- Rospatent
- TIPO
- IPO India
06 / Strategic value
Lapis LumenJust nowLapis LumenJust nowLapis LumenJust now
Confidence in every decision, backed by Lapis Research.
Lapis Lumen gives your team the intelligence and evidence to act on, and defend, the decisions that matter to your company.
01
Prepare for investor and board questions.
Evidence-backed competitive, landscape and IP intelligence for investor meetings, board reviews and due diligence, so you can prove your intelligence with confidence.
In your SlackSlack
Search Lapis Research
# board-prep
Priya9:12 AM
Investor call at 2. They will ask who else is working on continuous enzymatic manufacturing.
Sam9:13 AM
@Lapis Lumen who else is working on this?
Lapis LumenApp9:13 AM
4 organizations are moving on your route, 2 of them new this quarter.
Competitor activity · your process route
- Northwind Therapeutics · Patent application · 7 weeks agoNew
- Delta Lab · Preprint · bioRxivNew
- Kestrel Process Labs · EP filing · Mar 2026
- Basel Bioworks · Licensing activity · Feb 2026
11 sources · every answer datedOpen brief
Message #board-prep
02
Decide what to build next.
See which technical routes are becoming crowded, where your position remains distinct and which work should be accelerated, redesigned, licensed or paused.
In your roadmap doc
FY27 program roadmap
Owner: Priya · Updated weekly
Next four quarters
| Quarter | Workstream |
| Q3 | Process validation |
| Q4 | Route A optimisation |
| Q4 | Pilot line |
| Q1 | Scale-up partner outreach |
| Q2 | Series B raise |
Lapis LumenJust nowAdd: “File continuation on claim 3”
A competitor filed on your process route 7 weeks ago.
3 sources
Lapis LumenJust nowReplace: “A” with “C”
Route A is crowded by 4 organizations. Route C is not.
5 sources
Lapis LumenJust nowReplace: “Q1” with “Q4”
Two of your three target partners are already in talks.
2 sources
03
Find the right partners and licensors.
Identify the organizations, technologies and opportunities most relevant to your program before you open a partnership, licensing or counsel conversation.
Email, LinkedIn or in person
New messageEmail
ToHead of Licensing, Basel Bioworks
SubjectLicensing EP 4 219 447 A1
Hello,
We are building a continuous enzymatic manufacturing process, and EP 4 219 447 A1 reads close to our route. Would you be open to a call about licensing it?
Drafted from your Lapis Lumen brief
Send3 records attached
07 / The advantage
Intelligence no one else has: deeper coverage, connected evidence, judged against your technology.
We have the deepest supply of research intelligence, thousands of signals across messy sources. We find important technologies, competitors and threats that you would never search for.
Depth of coverageOur analysis engine connects companies, subsidiaries, researchers and patents to reveal who is behind a development and what it means for your technology.
Filed elsewhere, resolved to the parentOnboarding takes six minutes, not six months. Brief your first research agent and intelligence starts arriving in the same session, with no procurement cycle and no implementation quarter.
Measured across three onboardingsWe model a digital twin of your technology, including current and planned claims, research areas and capabilities. The model finds relevant developments even when terminology differs and filters out irrelevant keyword matches.
Relevance judged against your program
- 01
See what everyone else misses.
We have the deepest supply of research intelligence, thousands of signals across messy sources. We find important technologies, competitors and threats that you would never search for.
Depth of coverage - 02
We connect the dots for you.
Our analysis engine connects companies, subsidiaries, researchers and patents to reveal who is behind a development and what it means for your technology.
Filed elsewhere, resolved to the parent - 03
Get started in six minutes.
Onboarding takes six minutes, not six months. Brief your first research agent and intelligence starts arriving in the same session, with no procurement cycle and no implementation quarter.
Measured across three onboardings - 04
A digital twin of your technology.
We model a digital twin of your technology, including current and planned claims, research areas and capabilities. The model finds relevant developments even when terminology differs and filters out irrelevant keyword matches.
Relevance judged against your program